“Intravenous Immunoglobulin Costs Are Higher for off-Label Indications in a High-Complexity Hospital in Colombia”. Universitas Medica, vol. 64, no. 4, Jan. 2024, https://doi.org/10.11144/Javeriana.umed64-4.offl.